- AuthorisedTherapeutic confirmatory (Phase III)
An Open-Label, Single-Arm, 3-Year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Subjects with Stargardt Disease
This study is looking at a new medicine called tinlarebant (LBS-008) for Stargardt Disease. It's a 3-year extension study to see if the medicine is safe and how well people tolerate it over time. Researchers will check for changes in eye health using special photographs.
For: Stargardt DiseaseNetherlands · France · Belgium - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Phase 3, Multicenter, Randomized, Double-Masked, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Tinlarebant in the Treatment of Stargardt Disease in Adolescent Subjects
This study is looking into a new medication called Tinlarebant for young people with Stargardt disease. It aims to see if the medication is safe and can slow down the development of the condition over about two years, compared to a dummy treatment.
For: Stargardt DiseaseFrance · Netherlands · Belgium